Teva Pharmaceutical Industries (TEVA) Assets: 2009-2025
Historic Assets for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $39.9 billion.
- Teva Pharmaceutical Industries' Assets fell 4.55% to $39.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $39.9 billion, marking a year-over-year decrease of 4.55%. This contributed to the annual value of $39.3 billion for FY2024, which is 9.55% down from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Assets stood at $39.9 billion for Q3 2025, which was down 0.69% from $40.1 billion recorded in Q2 2025.
- Teva Pharmaceutical Industries' Assets' 5-year high stood at $49.2 billion during Q2 2021, with a 5-year trough of $38.4 billion in Q1 2025.
- In the last 3 years, Teva Pharmaceutical Industries' Assets had a median value of $41.8 billion in 2024 and averaged $41.4 billion.
- Data for Teva Pharmaceutical Industries' Assets shows a maximum YoY declined of 11.43% (in 2021) over the last 5 years.
- Teva Pharmaceutical Industries' Assets (Quarterly) stood at $47.7 billion in 2021, then fell by 7.67% to $44.0 billion in 2022, then fell by 1.21% to $43.5 billion in 2023, then decreased by 9.55% to $39.3 billion in 2024, then fell by 4.55% to $39.9 billion in 2025.
- Its Assets was $39.9 billion in Q3 2025, compared to $40.1 billion in Q2 2025 and $38.4 billion in Q1 2025.